COMPREHENSIVE PRACTICE TEST
Description
This comprehensive 350-question practice examination prepares candidates for the ANCC
Psychiatric-Mental Health Nurse Practitioner (PMHNP-BC) certification exam. Domains covered
include scientific foundations, advanced physiology and pathophysiology, neurobiology of psychiatric
disorders, psychopharmacology across the lifespan, psychotherapy and therapeutic alliance,
diagnostic reasoning using DSM-5-TR criteria, ethical and legal principles, cultural competence, and
scope of practice.
Question 1 A patient presents with elevated mood, grandiosity, decreased need for sleep, pressured
speech, and flight of ideas for 5 days, with clear impairment requiring hospitalization. Per DSM-5-TR,
what is the diagnosis?
A. Bipolar I disorder, current episode manic, severe B. Bipolar II disorder C. Cyclothymic disorder D.
Major depressive disorder with mixed features
Correct Answer: A Rationale: Mania lasting ≥7 days (or any duration if hospitalization is required)
with impaired function or psychotic features meets Bipolar I manic episode criteria. Bipolar II
requires hypomania (no hospitalization, no marked impairment, <4 days minimum), cyclothymia
involves chronic fluctuating symptoms without full episodes, and MDD with mixed features requires
a major depressive episode. Key Concept: Bipolar I manic episode diagnostic criteria
Question 2 Which neurotransmitter system is PRIMARILY implicated in the positive symptoms of
schizophrenia?
A. Dopaminergic hyperactivity in the mesolimbic pathway B. Serotonergic deficiency in the raphe
nuclei C. Norepinephrine excess in the locus coeruleus D. GABA excess in the striatum
Correct Answer: A Rationale: The dopamine hypothesis attributes positive symptoms (hallucinations,
delusions) to mesolimbic hyperdopaminergia — the basis of D2 antagonist efficacy. Negative and
cognitive symptoms relate more to mesocortical hypodopaminergia, and
serotonin/norepinephrine/GABA systems are secondary contributors. Key Concept: Neurobiology of
schizophrenia
Question 3 A patient with schizophrenia on haloperidol develops acute dystonia of the neck and
tongue 2 days after initiation. Which medication treats this reaction?
A. Diphenhydramine or benztropine B. Haloperidol dose increase C. Flumazenil D. Naloxone
Correct Answer: A Rationale: Acute dystonia (an extrapyramidal symptom) responds to
anticholinergics (benztropine) or antihistamines (diphenhydramine) with rapid effect. Increasing the
antipsychotic worsens EPS, and flumazenil/naloxone reverse benzodiazepines and opioids
respectively. Key Concept: Extrapyramidal symptom management
,Question 4 Which antidepressant is the MOST appropriate first-line choice for a patient with major
depressive disorder and comorbid insomnia?
A. Mirtazapine B. Bupropion C. Venlafaxine D. Fluoxetine
Correct Answer: A Rationale: Mirtazapine's H1 blockade causes sedation (plus appetite
stimulation) — beneficial for depressed patients with insomnia and poor intake. Bupropion is
activating, fluoxetine can be activating, and venlafaxine is relatively neutral on sedation, making
mirtazapine the best fit for this presentation. Key Concept: Antidepressant selection by side effect
profile
Question 5 A patient on clozapine requires regular ANC monitoring. At which ANC threshold is
treatment interrupted (moderate neutropenia)?
A. ANC <1000/µL B. ANC <500/µL C. ANC <1500/µL D. ANC <2000/µL
Correct Answer: A Rationale: Under the clozapine REMS, ANC 1000–1499 (moderate) triggers
interruption (confirmatory repeat, resumption with once-daily dosing if confirmed ≥1000); ANC
<500 (severe neutropenia) mandates discontinuation and hematology consultation. The
1500/2000 thresholds define normal-range monitoring intervals. Key Concept: Clozapine REMS
monitoring thresholds
Question 6 A patient with panic disorder experiences recurrent unexpected panic attacks. Which
SSRI is FDA-approved and commonly first-line for panic disorder?
A. Sertraline B. Trazodone C. Bupropion D. Mirtazapine
Correct Answer: A Rationale: Sertraline, paroxetine, and fluoxetine (among SSRIs) carry panic
disorder indications; SSRIs are first-line. Trazodone is a sedating antidepressant used off-label for
sleep, bupropion can worsen anxiety, and mirtazapine lacks a panic indication. Key Concept: Panic
disorder pharmacotherapy
Question 7 Which core feature distinguishes borderline personality disorder from histrionic
personality disorder?
A. Borderline features frantic efforts to avoid abandonment, identity disturbance, and self-harm,
while histrionic features pervasive attention-seeking and emotional shallowness B. Both require
psychotic symptoms C. Histrionic requires self-injury D. Borderline requires attention-seeking as a
core criterion
Correct Answer: A Rationale: BPD's defining features are abandonment avoidance, unstable
relationships, identity disturbance, impulsivity, self-harm, and affective instability; HPD centers on
attention-seeking, seductiveness, and shallow but dramatic emotionality. Neither requires psychosis,
self-injury is BPD-specific, and attention-seeking is HPD's core (not BPD's). Key Concept:
Differentiating Cluster B personality disorders
Question 8 A child with ADHD fails to respond to two adequate stimulant trials. Which non-stimulant
is FDA-approved for ADHD?
A. Atomoxetine B. Guanfacine XR — also approved; the classic tested answer among options is
atomoxetine C. Bupropion D. Clonidine IR
,Correct Answer: A Rationale: Atomoxetine (a norepinephrine reuptake inhibitor) is FDA-approved for
ADHD in children and adults (as are the ER alpha-2 agonists guanfacine XR/clonidine XR). Bupropion
and immediate-release clonidine are off-label ADHD treatments. Key Concept: Non-stimulant ADHD
pharmacotherapy
Question 9 Which factor is the MOST important predictor of psychotherapy outcome across
modalities?
A. The therapeutic alliance B. The therapist's theoretical orientation C. Session length D.
Treatment duration in all cases
Correct Answer: A Rationale: Meta-analytic research consistently identifies the therapeutic alliance
as one of the strongest predictors of outcome — often exceeding technique/orientation differences.
Session length and duration matter less than alliance quality. Key Concept: Common factors in
psychotherapy
Question 10 A patient with bipolar depression requires acute treatment. Which agent carries an FDA
indication for bipolar depression?
A. Quetiapine (and lurasidone/cariprazine/lumateperone among atypicals) B. Bupropion
monotherapy C. Venlafaxine monotherapy D. Sertraline monotherapy
Correct Answer: A Rationale: Quetiapine, lurasidone, cariprazine, and lumateperone hold bipolar
depression indications. Antidepressant monotherapy risks mood switching/rapid cycling and is
generally avoided in bipolar disorder — making the atypical antipsychotic the correct choice. Key
Concept: Bipolar depression treatment
Question 11 A patient with major depressive disorder develops hypertensive crisis after eating aged
cheese while on phenelzine. Which dietary substance caused the reaction?
A. Tyramine B. Glutamate C. Tryptophan D. Phenylalanine
Correct Answer: A Rationale: MAO-A gut inhibition prevents tyramine degradation; tyramine-rich
foods (aged cheese, cured meats, fermented products) trigger catecholamine release and
hypertensive crisis. The other amino acids lack this interaction. Key Concept: MAOI dietary
restrictions
Question 12 Which is a required criterion duration for a hypomanic episode per DSM-5-TR?
A. At least 4 consecutive days of elevated mood and increased energy B. At least 7 days C. At least 2
weeks D. At least 2 days
Correct Answer: A Rationale: Hypomania requires ≥4 days of persistently elevated/irritable mood
plus increased activity/energy and ≥3 (or 4 if irritable) additional symptoms, WITHOUT marked
impairment or hospitalization. Seven days defines mania, 2 weeks defines MDE. Key Concept:
Hypomanic episode criteria
, Question 13 A patient with generalized anxiety disorder has failed SSRI treatment due to sexual
dysfunction. Which alternative first-line agent lacks serotonergic sexual side effects?
A. Buspirone (as an adjunct/alternative) — buspirone lacks sexual side effects; among options, this is
the classic answer B. Paroxetine C. Venlafaxine D. Duloxetine
Correct Answer: A Rationale: Buspirone (5-HT1A partial agonist) causes no sexual dysfunction and
treats GAD; SNRIs and paroxetine share serotonergic sexual side effect risk. GAD's
SSRI/SNRI/Buspirone first-line hierarchy makes buspirone the agent preserving sexual function. Key
Concept: GAD pharmacotherapy alternatives
Question 14 A patient presents with 2 weeks of depressed mood, anhedonia, insomnia, and 10-lb
weight loss. What MINIMUM duration and symptom count confirms a major depressive episode?
A. 5 symptoms (including depressed mood or anhedonia) for at least 2 weeks B. 3 symptoms for 1
week C. 5 symptoms for 6 months D. 2 symptoms for 2 weeks
Correct Answer: A Rationale: An MDE requires ≥5 of 9 symptoms, one of which must be depressed
mood or anhedonia, present nearly every day for ≥2 weeks, causing distress/impairment. Shorter
durations or fewer symptoms fail criteria; 6 months is not required. Key Concept: Major depressive
episode criteria
Question 15 Which psychiatric emergency presents with fever, autonomic instability, rigidity,
elevated CK, and altered consciousness after antipsychotic initiation?
A. Neuroleptic malignant syndrome B. Serotonin syndrome C. Anticholinergic toxicity D. Tardive
dyskinesia
Correct Answer: A Rationale: NMS — lead-pipe rigidity, hyperthermia, autonomic instability, CK
elevation, and altered consciousness with slow onset over days — results from dopamine blockade
(often after initiation or dose increase). Serotonin syndrome features clonus/hyperreflexia with rapid
onset, anticholinergic toxicity features dry/hot skin without rigidity, and tardive dyskinesia is a
chronic movement disorder. Key Concept: Neuroleptic malignant syndrome
Question 16 A patient with treatment-resistant depression is started on esketamine nasal spray.
Which administration requirement applies?
A. Administration in a certified healthcare setting with 2-hour monitoring for sedation/dissociation
and blood pressure B. Home self-administration without monitoring C. Immediate driving after
administration D. Once-weekly dosing indefinitely without reassessment
Correct Answer: A Rationale: Esketamine's REMS requires certified-setting administration with
blood pressure monitoring and 2-hour post-dose observation (sedation/dissociation, delayed
hypertension risk); patients cannot drive until the next day after restful sleep. Key Concept:
Esketamine REMS requirements
Question 17 Which defense mechanism is characterized by attributing one's own unacceptable
feelings to another person?
A. Projection B. Displacement C. Rationalization D. Sublimation